Blood thinners can be an effective solution to those suffering from cardiac and blood vessel diseases that cause clotting. Anticoagulants cause the blood to thin and more easily move through the blood stream. While the benefits of blood thinners is substantial, the U.S. Food and Drug Administration and physicians prescribing blood thinners often are forced to weigh the benefits with the life threatening side effects these blood thinners can cause.
All anticoagulants come with a risk of serious bleeding incidents. Since the blood thins and does not clot when hemorrhaging occurs, the loss of blood can be substantial. Most blood thinners require the patient to be vigilant in taking precautions against these bleeding incidents. Some coagulants, such as Coumadin and Pradaxa, require frequent check-ups and monitoring by physicians to regulate the amount of drug within the blood stream. Other drugs, like Xarelto, do not require these types of precautions and are therefore more dangerous to the patients prescribed it.
In comparison to similar drugs, Xarelto is more dangerous because of the lack of antidote. If a bleeding incident occurs due to Xarelto, the patient must wait until the drug leaves the blood stream. Other medications on the market have reversal agents that an individual can take during a bleeding incident to stop hemorrhaging from becoming life threatening.
While bleeding risks are a side effect of any anticoagulant, the risk of these types of incidents may increase with the use of other medications. Pain relievers have blood thinning properties that, when taken with anticoagulants, can increase the susceptibility of patients to bleeding accidents.
If you are interested in learning more about Xarelto and the legal options you have to receive compensation for the pain and suffering you sustained due to negligent drug manufacturers, click here.